Pamela L Clemens
2PUBLICATIONS
39CO-AUTHORS

Get your video featured.

Get your video featured.
Publications (2)
Sort by Publication Date:
|Jun 10, 2024
Subcutaneous Versus Intravenous Amivantamab, Both in Combination With Lazertinib, in Refractory Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: Primary Results From the Phase III PALOMA-3 Study.Natasha B Leighl, Hiroaki Akamatsu, Sun Min Lim
Pageof 1
Frequent Collaborators
2 joint publications
Nahor Haddish-Berhane
1 joint publications
Natasha B Leighl
1 joint publications
Hiroaki Akamatsu
1 joint publications
Sun Min Lim
1 joint publications
Ying Cheng
1 joint publications
Anna R Minchom
1 joint publications
Melina E Marmarelis
1 joint publications
Rachel E Sanborn
1 joint publications
James Chih-Hsin Yang
1 joint publications
Thomas John